» Authors » Pierre-Jean Monteyrol

Pierre-Jean Monteyrol

Explore the profile of Pierre-Jean Monteyrol including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 123
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vecchierini M, Attali V, Collet J, dOrtho M, Goutorbe F, Kerbrat J, et al.
J Clin Sleep Med . 2021 Jun; 17(8):1695-1705. PMID: 34165074
Study Objectives: Mandibular advancement devices (MADs) are an alternative to continuous positive airway pressure for the management of obstructive sleep apnea (OSA). The ORthèse d'avanCée mAndibulaire dans le traitement en...
2.
Attali V, Vecchierini M, Collet J, dOrtho M, Goutorbe F, Kerbrat J, et al.
Sleep Med . 2019 Oct; 63:64-74. PMID: 31606651
Objective/background: Mandibular repositioning device (MRD) therapy is an alternative to continuous positive airway pressure (CPAP). The Orkney Complex Disease Study-ORCADES study is assessing the long-term efficacy and tolerability of MRD...
3.
Catella C, Micoulaud-Franchi J, Monteyrol P, Cuny E, Vanderveken O, DIncau E, et al.
Eur Arch Otorhinolaryngol . 2019 Jan; 276(3):901-909. PMID: 30689040
Introduction: A new approach to treat obstructive sleep apnea (OSA) is upper airway stimulation therapy (UAS). Electrical pulses applied to the hypoglossal nerve induce tongue protrusion, increase airway patency and...
4.
Goutorbe F, Kerbrat J, Lavergne F, Monteyrol P, Morin L, Meurice J, et al.
Sleep Breath . 2018 Dec; 23(3):837-848. PMID: 30580418
Purpose: Mandibular repositioning devices (MRDs) are an effective treatment option for obstructive sleep apnea syndrome (OSAS), particularly in patients who refuse or cannot tolerate continuous positive airway pressure (CPAP). However,...
5.
Philip P, Heiser C, Bioulac S, Altena E, Penchet G, Cuny E, et al.
Neurology . 2018 Jul; 91(7):e615-e619. PMID: 30021916
Objectives: To quantify the effect of hypoglossal nerve stimulation (HNS), a novel therapy for patients with obstructive sleep apnea, on objective level of alertness (measured with Maintenance of Wakefulness Test...
6.
Micoulaud-Franchi J, Coste O, Bioulac S, Guichard K, Monteyrol P, Ghorayeb I, et al.
Sleep Breath . 2018 Jun; 23(1):217-226. PMID: 29946945
Purpose: The Self-Efficacy Measure for Sleep Apnea (SEMSA) is a 26-item self-questionnaire composed of three factors: risk perception of obstructive sleep apnea syndrome (OSAS), benefit of continuous positive airway pressure...
7.
Philip P, Bioulac S, Altena E, Morin C, Ghorayeb I, Coste O, et al.
PLoS One . 2018 Apr; 13(4):e0195343. PMID: 29617414
This study explores the association between specific insomnia symptoms (sleep onset, sleep maintenance and early morning awakenings symptoms) and self-efficacy (perceived self-confidence in the ability to use CPAP) with CPAP...
8.
Afonso Delgado L, Micoulaud Franchi J, Monteyrol P, Philip P
Presse Med . 2016 Jan; 45(2):183-92. PMID: 26796478
Obstructive sleep apnea hypopnea syndrome (OSAHS) is a common disorder that has been identified as a contributor to cardiovascular disease making it a major public health problem. Continuous positive airway...
9.
Vecchierini M, Attali V, Collet J, dOrtho M, El Chater P, Kerbrat J, et al.
Sleep Med . 2015 Sep; 19:131-40. PMID: 26364869
Background: Mandibular repositioning devices (MRDs) are usually recommended as the first therapy option in patients with mild-to-moderate obstructive sleep apnoea (OSA). However, data on the long-term efficacy of MRDs are...
10.
Guilleminault C, Huang Y, Quo S, Monteyrol P, Lin C
Sleep Med . 2012 Oct; 14(1):37-44. PMID: 23026504
Objectives: The study aims to better understand the reappearance of sleep apnoea in adolescents considered cured of obstructive sleep apnoea (OSA) following adenotonsillectomy and orthodontic treatment. Study Design: The study...